References
S. Moncada, R. M. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,”Pharmacol. Rev.,43, No. 2, 109–142 (1991).
R. M. J. Palmer, A. G. Ferridge, and S. Moncada, “Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor,”Nature,327, 524–526 (1987).
T. M. Lincoln, T. L. Cornwell, and P. Komalavilas, et al., “The nitric oxide-cyclic GMP signalling system,” in:Biochemistry of Smooth Muscle Contraction, E. Barany (ed.), Acad. Press, New York (1996), pp. 257–268.
H. R. Weiss, J. D. Sadoff, P. M. Sholz, and R. E. Klabunde, “Nitric oxide reduces myocardial contractility in isoproterenol-stimulated rat hearts by a mechanism independent of cyclic GMP or cyclic AMP,”Pharmacology,55, 202–210 (1997).
V. M. Bolotina, S. Najibi, J. J. Palacino, et al., “Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle,”Nature,368, No. 6474, 850–853 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andruchov, O.Y., Sagach, V.F. Effects of nitric oxide on the contractile activity of the skinned rat portal vein and papillary muscle. Neurophysiology 32, 204–205 (2000). https://doi.org/10.1007/BF02506575
Issue Date:
DOI: https://doi.org/10.1007/BF02506575